Immune-mediated neuropathy with Epstein-Barr virus-positive T-cell lymphoproliferative disease.
A 47-year-old man with Epstein-Barr virus (EBV)-positive T/NK- cell lymphoproliferative disease (EBV-T/NK-LPD) developed acute-onset weakness. A nerve conduction study showed a conduction block in both the proximal and most distal segments. Although the patient's neuropathy transiently responded to intravenous immunoglobulin, it was progressive for at least 25 days until the start of prednisolone (PSL) administration, after which it remarkably improved. The neuropathy further improved after allogeneic bone marrow transplantation (BMT). The present patient's clinical course is not consistent with that of typical Guillain-Barré syndrome. This case suggests that EBV-T/NK-LPD can cause progressive immune-mediated neuropathy as a result of chronic EBV antigen presentation and can be treated with PSL and BMT.
Department of Neurology and Neurological Sciences, Graduate School, Tokyo Medical and Dental University, Japan.
Takaaki
T
Hattori
Ayako
A
Arai
Takanori
T
Yokota
Ken-Ichi
K
Imadome
Hiroyuki
H
Tomimitsu
Osamu
O
Miura
Hidehiro
H
Mizusawa
D016026:Bone Marrow Transplantation; D003937:Diagnosis, Differential; D020031:Epstein-Barr Virus Infections / Q000150:complications* / Q000628:therapy*; D020275:Guillain-Barre Syndrome / Q000175:diagnosis; D006801:Humans; D007136:Immunoglobulins / Q000627:therapeutic use; D007564:Japan; D016399:Lymphoma, T-Cell / Q000150:complications* / Q000628:therapy* / Q000821:virology; D008297:Male; D008875:Middle Aged; D010523:Peripheral Nervous System Diseases / Q000150:complications* / Q000175:diagnosis / Q000628:therapy*; D011239:Prednisolone / Q000627:therapeutic use; D016896:Treatment Outcome
D007136:Immunoglobulins; D011239:Prednisolone